{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:21:37Z","timestamp":1791066097685,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Neurosciences"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.tins.2012.05.005","type":"journal-article","created":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T07:44:34Z","timestamp":1340005474000},"page":"587-596","source":"Crossref","is-referenced-by-count":173,"title":["\u03ba-opioid receptor\/dynorphin system: genetic and pharmacotherapeutic implications for addiction"],"prefix":"10.1016","volume":"35","author":[{"given":"Eduardo R.","family":"Butelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Yuferov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jeanne","family":"Kreek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tins.2012.05.005_bib0005","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1073\/pnas.76.12.6666","article-title":"Dynorphin-(1\u201313), an extraordinarily potent opioid peptide","volume":"76","author":"Goldstein","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tins.2012.05.005_bib0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/mcne.1994.1015","article-title":"Kappa 1 receptor mRNA distribution in the rat CNS: comparison to kappa receptor binding and prodynorphin mRNA","volume":"5","author":"Mansour","year":"1994","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.tins.2012.05.005_bib0015","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1073\/pnas.92.15.7006","article-title":"Kappa-opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system","volume":"92","author":"Simonin","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tins.2012.05.005_bib0020","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3565(24)36877-6","article-title":"Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands","volume":"282","author":"Zhu","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tins.2012.05.005_bib0025","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/00008571-200412000-00002","article-title":"Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction","volume":"14","author":"Yuferov","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.tins.2012.05.005_bib0030","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/306611a0","article-title":"Isolation and structural organization of the human preproenkephalin B gene","volume":"306","author":"Horikawa","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.tins.2012.05.005_bib0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0006-8993(95)00928-J","article-title":"The cloned mu, delta and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores","volume":"700","author":"Mansour","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.tins.2012.05.005_bib0040","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","article-title":"Psychotomimesis mediated by kappa opiate receptors","volume":"233","author":"Pfeiffer","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.tins.2012.05.005_bib0045","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1073\/pnas.182234399","article-title":"Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist","volume":"99","author":"Roth","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tins.2012.05.005_bib0050","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/jpet.105.092304","article-title":"Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats","volume":"316","author":"Carlezon","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tins.2012.05.005_bib0055","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00213-003-1716-3","article-title":"Effect of the kappa opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL\/6J mice","volume":"173","author":"Zhang","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tins.2012.05.005_bib0060","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00213-004-2087-0","article-title":"Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors","volume":"179","author":"Zhang","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tins.2012.05.005_bib0065","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1471-4159.2004.02589.x","article-title":"Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects","volume":"90","author":"Shirayama","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2012.05.005_bib0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2007.05.045","article-title":"Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies","volume":"570","author":"Zhang","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tins.2012.05.005_bib0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuropharm.2011.06.014","article-title":"Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats","volume":"62","author":"Chartoff","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tins.2012.05.005_bib0080","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.tins.2012.05.005_bib0085","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1360-0443.1996.tb03580.x","article-title":"Validity of the SCID in substance abuse patients","volume":"91","author":"Kranzler","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.tins.2012.05.005_bib0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1300\/J069v17n03_07","article-title":"Psychiatric comorbidity in methadone maintained patients","volume":"17","author":"Mason","year":"1998","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.tins.2012.05.005_bib0095","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00001756-199305000-00020","article-title":"Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum","volume":"4","author":"Daunais","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.tins.2012.05.005_bib0100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0169-328X(93)90133-A","article-title":"\u2018Binge\u2019 cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen","volume":"19","author":"Spangler","year":"1993","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.tins.2012.05.005_bib0105","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1097\/00001756-199408150-00018","article-title":"Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors","volume":"5","author":"Unterwald","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.tins.2012.05.005_bib0110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0306-4522(96)00363-6","article-title":"Delayed occurrence of enhanced striatal preprodynorphin gene expression in behaviorally sensitized rats: differential long-term effects of intermittent and chronic morphine administration","volume":"76","author":"Tjon","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2012.05.005_bib0115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0169-328X(99)00021-2","article-title":"Acute intermittent morphine increases preprodynorphin and kappa opioid receptor mRNA levels in the rat brain","volume":"66","author":"Wang","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.tins.2012.05.005_bib0120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2009.08.062","article-title":"The dynorphin\/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors","volume":"1314","author":"Bruchas","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.tins.2012.05.005_bib0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-010-1825-8","article-title":"The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse","volume":"210","author":"Wee","year":"2010","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tins.2012.05.005_bib0130","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00018-011-0844-x","article-title":"The dynorphin\/kappa-opioid receptor system and its role in psychiatric disorders","volume":"69","author":"Tejeda","year":"2012","journal-title":"Cell. Mol. Life. Sci."},{"key":"10.1016\/j.tins.2012.05.005_bib0135","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1126\/science.282.5387.298","article-title":"Transition from moderate to excessive drug intake: change in hedonic set point","volume":"282","author":"Ahmed","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.tins.2012.05.005_bib0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002130100744","article-title":"Predictable individual differences in the initiation of cocaine self-administration by rats under extended-access conditions are dose-dependent","volume":"157","author":"Mantsch","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tins.2012.05.005_bib0145","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.tins.2011.06.001","article-title":"Neurobiology of the incubation of drug craving","volume":"34","author":"Pickens","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tins.2012.05.005_bib0150","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1749-6632.2000.tb06683.x","article-title":"Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine","volume":"909","author":"Kreek","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tins.2012.05.005_bib0155","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","article-title":"1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial","volume":"361","author":"Kakko","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.tins.2012.05.005_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2011.05.033","article-title":"The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review","volume":"119","author":"Dunn","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.tins.2012.05.005_bib0165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/7854_2009_20","article-title":"Neural substrates of psychostimulant withdrawal-induced anhedonia","volume":"3","author":"D'Souza","year":"2010","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.tins.2012.05.005_bib0170","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1523\/JNEUROSCI.4701-05.2006","article-title":"Role of cAMP response element-binding protein in the rat locus ceruleus: regulation of neuronal activity and opiate withdrawal behaviors","volume":"26","author":"Han","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2012.05.005_bib0175","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0022-3565(25)24578-5","article-title":"Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats","volume":"244","author":"Di Chiara","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tins.2012.05.005_bib0180","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF02244761","article-title":"Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimic dopamine release","volume":"115","author":"Spanagel","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tins.2012.05.005_bib0185","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0006-8993(92)90912-S","article-title":"Chronic cocaine alters brain mu opioid receptors","volume":"584","author":"Unterwald","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.tins.2012.05.005_bib0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0169-328X(95)00319-N","article-title":"Regulation of kappa opioid receptor mRNA in the rat brain by \u2018binge\u2019 pattern cocaine administration and correlation with preprodynorphin mRNA","volume":"38","author":"Spangler","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.tins.2012.05.005_bib0195","doi-asserted-by":"crossref","first-page":"7670","DOI":"10.1523\/JNEUROSCI.16-23-07670.1996","article-title":"Effects of binge pattern cocaine administration on dopamine D1 and D2 receptors in the rat brain: an in vivo study using positron emission tomography","volume":"16","author":"Tsukada","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2012.05.005_bib0200","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/nm1196-1225","article-title":"Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving","volume":"2","author":"Zubieta","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2012.05.005_bib0205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0006-8993(01)02269-7","article-title":"The frequency of cocaine administration impacts cocaine-induced receptor alterations","volume":"900","author":"Unterwald","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.tins.2012.05.005_bib0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/syn.10137","article-title":"Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study","volume":"46","author":"Volkow","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.tins.2012.05.005_bib0215","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopsych.2003.07.007","article-title":"Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence","volume":"55","author":"Bencherif","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2012.05.005_bib0220","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0022-3565(24)38026-7","article-title":"Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor","volume":"288","author":"Remmers","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tins.2012.05.005_bib0225","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.89.6.2046","article-title":"Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway","volume":"89","author":"Spanagel","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tins.2012.05.005_bib0230","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00213-003-1688-3","article-title":"Effect of the endogenous kappa opioid agonist dynorphin A(1\u201317) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL\/6J mice","volume":"172","author":"Zhang","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tins.2012.05.005_bib0235","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jneumeth.2005.12.018","article-title":"Quantitative no-net-flux microdialysis permits detection of increases and decreases in dopamine uptake in mouse nucleus accumbens","volume":"155","author":"Chefer","year":"2006","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.tins.2012.05.005_bib0240","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.neuropharm.2006.04.005","article-title":"\u03ba-opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration","volume":"51","author":"Doyon","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tins.2012.05.005_bib0245","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.physbeh.2007.05.039","article-title":"Ethanol alters the effect of kappa receptor ligands on dopamine release in the nucleus accumbens","volume":"92","author":"Lindholm","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.tins.2012.05.005_bib0250","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00213-005-0167-4","article-title":"Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats","volume":"183","author":"Beardsley","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tins.2012.05.005_bib0255","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejphar.2007.05.007","article-title":"Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn","volume":"569","author":"Carey","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tins.2012.05.005_bib0260","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","article-title":"The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system","volume":"28","author":"Land","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2012.05.005_bib0265","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1046\/j.1460-9568.2003.02636.x","article-title":"Temporal upregulation of prodynorphin mRNA in the primate striatum after cocaine self-administration","volume":"17","author":"Fagergren","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.tins.2012.05.005_bib0270","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1098\/rstb.2008.0089","article-title":"Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction","volume":"363","author":"Everitt","year":"2008","journal-title":"Philos. Trans. R. Soc. Lond. B: Biol. Sci"},{"key":"10.1016\/j.tins.2012.05.005_bib0275","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.neuroscience.2010.04.060","article-title":"Acute withdrawal from chronic escalating-dose binge cocaine administration alters kappa opioid receptor stimulation of [35S] guanosine 5\u2032-O-[gamma-thio]triphosphate acid binding in the rat ventral tegmental area","volume":"169","author":"Piras","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2012.05.005_bib0280","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.biopsych.2011.03.017","article-title":"Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats","volume":"70","author":"Knoll","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2012.05.005_bib0285","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nn1583","article-title":"Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction","volume":"8","author":"Kreek","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2012.05.005_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.57.1.1","article-title":"Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments","volume":"57","author":"Kreek","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tins.2012.05.005_bib0295","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1369-1600.2010.00248.x","article-title":"Cell-specific effects of variants of the 68-base pair tandem repeat on prodynorphin gene promoter activity","volume":"16","author":"Rouault","year":"2011","journal-title":"Addict. Biol."},{"key":"10.1016\/j.tins.2012.05.005_bib0300","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ajmg.b.30238","article-title":"Confirmation of the association between a polymorphism in the promoter region of the prodynorphin gene and cocaine dependence","volume":"139B","author":"Dahl","year":"2005","journal-title":"Am. J. Med. Genet. B: Neuropsychiatr. Genet."},{"key":"10.1016\/j.tins.2012.05.005_bib0305","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1369-1600.2007.00069.x","article-title":"Prodynorphin gene promoter repeat associated with cocaine\/alcohol codependence","volume":"12","author":"Williams","year":"2007","journal-title":"Addict. Biol."},{"key":"10.1016\/j.tins.2012.05.005_bib0310","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2006.02.038","article-title":"Genetic variant of prodynorphin gene is risk factor for methamphetamine dependence","volume":"400","author":"Nomura","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tins.2012.05.005_bib0315","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.mp.4001882","article-title":"Association of the kappa-opioid system with alcohol dependence","volume":"11","author":"Xuei","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2012.05.005_bib0320","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2011.02.042","article-title":"Prodynorphin promoter SNP associated with alcohol dependence forms noncanonical AP-1 binding site that may influence gene expression in human brain","volume":"1385","author":"Taqi","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.tins.2012.05.005_bib0325","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1369-1600.2009.00151.x","article-title":"An association of prodynorphin polymorphisms and opioid dependence in females in a Chinese population","volume":"14","author":"Clarke","year":"2009","journal-title":"Addict. Biol."},{"key":"10.1016\/j.tins.2012.05.005_bib0330","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/npp.2008.187","article-title":"A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain","volume":"34","author":"Yuferov","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tins.2012.05.005_bib0335","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1471-4159.2000.740472.x","article-title":"An allelic variation in the human prodynorphin gene promoter alters stimulus-induced expression","volume":"74","author":"Zimprich","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2012.05.005_bib0340","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/molbev\/msp276","article-title":"Multiple functional variants in cis modulate PDYN expression","volume":"27","author":"Babbitt","year":"2010","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.tins.2012.05.005_bib0345","doi-asserted-by":"crossref","first-page":"32618","DOI":"10.1074\/jbc.M504942200","article-title":"Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G","volume":"280","author":"Zhang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2012.05.005_bib0350","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1126\/science.282.5397.2272","article-title":"Regulation of cocaine reward by CREB","volume":"282","author":"Carlezon","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.tins.2012.05.005_bib0355","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1073\/pnas.0812491106","article-title":"Tissue plasminogen activator modulates the cellular and behavioral response to cocaine","volume":"106","author":"Maiya","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tins.2012.05.005_bib0360","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00213-009-1730-1","article-title":"Forebrain PENK and PDYN gene expression levels in three inbred strains of mice and their relationship to genotype-dependent morphine reward sensitivity","volume":"208","author":"Gieryk","year":"2010","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tins.2012.05.005_bib0365","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pbb.2011.07.013","article-title":"Regional mRNA expression of the endogenous opioid and dopaminergic systems in brains of C57Bl\/6J and 129P3\/J mice: strain and heroin effects","volume":"100","author":"Schlussman","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.tins.2012.05.005_bib0370","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1601-183X.2008.00410.x","article-title":"Genetic susceptibility to heroin addiction: a candidate gene association study","volume":"7","author":"Levran","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.tins.2012.05.005_bib0375","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.mp.4002035","article-title":"The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk","volume":"13","author":"Zhang","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2012.05.005_bib0380","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/hmg\/ddn068","article-title":"A regulatory variation in OPRK1, the gene encoding the kappa-opioid receptor, is associated with alcohol dependence","volume":"17","author":"Edenberg","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2012.05.005_bib0385","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1523\/JNEUROSCI.0186-05.2005","article-title":"Retinoic acid-induced chromatin remodeling of mouse kappa opioid receptor gene","volume":"25","author":"Park","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2012.05.005_bib0390","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.neuroscience.2007.12.015","article-title":"Epigenetic regulation of kappa opioid receptor gene in neuronal differentiation","volume":"151","author":"Park","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2012.05.005_bib0395","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1369-1600.2011.00323.x","article-title":"Prodynorphin CpG-SNPs associated with alcohol dependence: elevated methylation in the brain of human alcoholics","volume":"16","author":"Taqi","year":"2011","journal-title":"Addict. Biol."},{"key":"10.1016\/j.tins.2012.05.005_bib0400","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/FPC.0b013e32833eecbc","article-title":"Tissue-specific DNA methylation of the human prodynorphin gene in post-mortem brain tissues and PBMCs","volume":"21","author":"Yuferov","year":"2011","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.tins.2012.05.005_bib0405","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/clpt.2010.175","article-title":"Breaking barriers in the genomics and pharmacogenetics of drug addiction","volume":"88","author":"Ho","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tins.2012.05.005_bib0410","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-8993(95)00306-B","article-title":"Kappa opioid inhibition of morphine and cocaine self-administration in rats","volume":"681","author":"Glick","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.tins.2012.05.005_bib0415","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0022-3565(24)36769-2","article-title":"Effects of kappa opioids on cocaine self-administration by rhesus monkeys","volume":"282","author":"Negus","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tins.2012.05.005_bib0420","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s002130051016","article-title":"U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking","volume":"144","author":"Schenk","year":"1999","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tins.2012.05.005_bib0425","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-3565(24)29312-5","article-title":"Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans","volume":"299","author":"Walsh","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tins.2012.05.005_bib0430","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0376-8716(80)90323-3","article-title":"Efficacy of clonidine in opiate withdrawal: a study of thirty patients","volume":"6","author":"Gold","year":"1980","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.tins.2012.05.005_bib0435","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/syn.20436","article-title":"Downregulation of kappa-opioid receptors in basolateral amygdala and septum of rats withdrawn for 14 days from an escalating dose \u2018binge\u2019 cocaine administration paradigm","volume":"61","author":"Bailey","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.tins.2012.05.005_bib0440","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF02245071","article-title":"Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay","volume":"115","author":"Broadbear","year":"1994","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tins.2012.05.005_bib0445","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0006-8993(03)02938-X","article-title":"Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys","volume":"982","author":"Ko","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.tins.2012.05.005_bib0450","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1124\/mol.111.074195","article-title":"Duration of action of a broad range of selective kappa opioid receptor antagonists is positively correlated with c-Jun N-terminal kinase-1 activation","volume":"80","author":"Melief","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tins.2012.05.005_bib0455","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1124\/jpet.111.185108","article-title":"Pharmacological characterization of 2-methyl-N-((2\u2032-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for \u03ba-opioid receptors","volume":"339","author":"Grimwood","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tins.2012.05.005_bib0460","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrd897","article-title":"Pharmacotherapy of addictions","volume":"1","author":"Kreek","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tins.2012.05.005_bib0465","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/sj.npp.1300811","article-title":"Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?","volume":"30","author":"Bart","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tins.2012.05.005_bib0470","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.bmcl.2009.02.078","article-title":"Syntheses of novel high affinity ligands for opioid receptors","volume":"19","author":"Wentland","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tins.2012.05.005_bib0475","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/j.bmc.2011.03.052","article-title":"Synthesis and binding affinity of novel mono- and bivalent morphinan ligands for kappa, mu, and delta opioid receptors","volume":"19","author":"Zhang","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.tins.2012.05.005_bib0480","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/128_2010_82","article-title":"Synthesis of neoclerodane diterpenes and their pharmacological effects","volume":"299","author":"Lovell","year":"2011","journal-title":"Top. Curr. Chem."},{"key":"10.1016\/j.tins.2012.05.005_bib0485","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature10939","article-title":"Structure of the human \u03ba-opioid receptor in complex with JDTic","volume":"485","author":"Wu","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.tins.2012.05.005_bib0490","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/syn.10198","article-title":"Differential gene expression in the rat caudate putamen after \u2018binge\u2019 cocaine administration: advantage of triplicate microarray analysis","volume":"48","author":"Yuferov","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.tins.2012.05.005_bib0495","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.mp.4001504","article-title":"Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden","volume":"9","author":"Bart","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2012.05.005_bib0500","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.neuropharm.2011.07.007","article-title":"Stress modulation of drug self-administration: Implications for addiction comorbidity with post-traumatic stress disorder","volume":"62","author":"Logrip","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tins.2012.05.005_bib0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2000.tb06672.x","article-title":"Partial opioids. Medications for the treatment of pain and drug abuse","volume":"909","author":"Bidlack","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tins.2012.05.005_bib0510","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.mp.4002147","article-title":"Genotype patterns that contribute to increased risk for or protection from developing heroin addiction","volume":"13","author":"Nielsen","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2012.05.005_bib0515","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1369-1600.2010.00265.x","article-title":"A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women","volume":"17","author":"Crystal","year":"2012","journal-title":"Addict. Biol."},{"key":"10.1016\/j.tins.2012.05.005_bib0520","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.npp.1300598","article-title":"Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden","volume":"30","author":"Bart","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tins.2012.05.005_bib0525","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/infdis\/jis264","article-title":"Association of polymorphisms of the mu opioid receptor gene with the severity of HIV infection and response to HIV treatment","volume":"205","author":"Proudnikov","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tins.2012.05.005_bib0530","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.biopsych.2006.07.012","article-title":"Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population","volume":"61","author":"Zhang","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2012.05.005_bib0535","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature10954","article-title":"Crystal structure of the \u03bc-opioid receptor bound to a morphinan antagonist","volume":"485","author":"Manglik","year":"2012","journal-title":"Nature"}],"container-title":["Trends in Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223612000884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223612000884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T10:15:18Z","timestamp":1743502518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166223612000884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":107,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0166223612000884"],"URL":"https:\/\/doi.org\/10.1016\/j.tins.2012.05.005","relation":{},"ISSN":["0166-2236"],"issn-type":[{"value":"0166-2236","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}